Renal cancer

Cinzia Ortega, Camillo Porta, Manuela Racca, Filippo Russo

Research output: Chapter in Book/Report/Conference proceedingChapter


Renal cell carcinoma (RCC) represents 2-3% of all cancers, with the highest incidence in Western countries and particularly in Europe, where the annual increase in the incidence of this disease is 2% [1, 2]. More than 50% of RCCs are diagnosed incidentally and are asymptomatic. The classic triad of flank pain, gross hematuria, and a palpable abdominal mass is seen in very few patients (6-10%). Paraneoplastic symptoms (e.g., hypertension, weight loss, pyrexia, neuromyopathy, anemia, polycythemia, amyloidosis, elevated erythrocyte sedimentation rate, and abnormal liver function) are found in approximately 20-30% of patients with RCC and about 20-30% of all RCC patients have metastatic disease.

Original languageEnglish
Title of host publicationImaging Tumor Response to Therapy
PublisherSpringer-Verlag Italia s.r.l.
Number of pages15
ISBN (Print)9788847026131, 9788847026124
Publication statusPublished - Jan 1 2012

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Renal cancer'. Together they form a unique fingerprint.

Cite this